Adding oxaliplatin to adjuvant fluoropyrimidine ups OS and DFS in MSI stage III colon cancer
08 Feb 2021
byChristina Lau
Adding oxaliplatin to adjuvant fluoropyrimidine improves overall survival (OS) and disease-free survival (DFS) in patients with microsatellite instability (MSI) stage III colon cancer, a pooled analysis of 12 randomized clinical trials has shown.
Adding oxaliplatin to adjuvant fluoropyrimidine ups OS and DFS in MSI stage III colon cancer
08 Feb 2021
